生理间接响应模型对omics驱动的定量系统的药理学模型
Aydar Uatay1, Louis Gall1, Linda Irons2
1Clinical Pharmacology & Quantitative Pharmacology, R&D Biopharmaceuticals, Cambridge, United Kingdom.
Journal of pharmaceutical sciences
|October 28, 2023
概括
定量系统药理学 (QSP) 建模整合了omics数据以了解药物机制. 这种方法通过解决机械模型中的当前挑战来增强药物开发.
科学领域:
- 药理学和药物开发领域
- 计算生物学 计算生物学
- 系统生物学 系统生物学
背景情况:
- 药物开发中的数学建模在过去的几十年里有了显著的进化.
- 药理动力学/药理动力学 (PK/PD) 建模已经发展到定量系统药理学 (QSP) 建模.
- 质量标准模型包含omics数据,以阐明药物作用机制.
研究的目的:
- 为了说明将omics数据集成到机械QSP模型中的方法.
- 提供从PK/PD到QSP建模的演变的概述.
- 讨论用于药物开发的综合QSP和omics建模的好处.
主要方法:
- 审查药物开发中的数学建模的演变.
- 介绍了omics数据集成到QSP模型中的例子.
- 讨论QSP和omics集成的挑战和未来方向.
主要成果:
- QSP建模代表了一种基于平台的方法,整合了omics数据.
- 数学方法的复杂性随着数据的可用性而增加.
- 机械QSP模型通过细胞信号网络来表征系统性药物效应.
结论:
- 将omics数据集成到QSP模型中,为药物开发提供了巨大的潜力.
- 解决目前数据集成方面的差距对于推进QSP至关重要.
- 未来的研究应该专注于协同QSP和omics建模策略.
相关概念视频
Pharmacokinetic Models: Overview
733
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
733
Pharmacokinetic Models: Comparison and Selection Criterion
79
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
79
Model Approaches for Pharmacokinetic Data: Physiological Models
52
Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue...
52
Analysis of Population Pharmacokinetic Data
267
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
267
Mechanistic Models: Overview of Compartment Models
90
Mechanistic models, a category encompassing both physiological and compartmental modeling, differ from empirical models' approaches to incorporating known factors about the systems being modeled. Empirical models describe data with minimal assumptions, while mechanistic models aim to provide a robust description of available data by specifying assumptions and integrating known factors about the system. Compartmental analysis is a key example of a mechanistic model in pharmacokinetics and...
90
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
74
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
74


